Devices placed on the EU market before 28 May 2026 and still sold after that date must be registered in the Eudamed UDI/Device module by 28 November 2026. For manufacturers who provide instructions for use in electronic form, the registration has one field that did not exist as an obligation before July 2025: the internet address of the eIFU. This post explains where that obligation comes from, what the address has to be, and what to check in the next twelve days.

Commission Decision (EU) 2025/2371, published in the Official Journal on 27 November 2025, declared four Eudamed modules functional: Actor registration, UDI/Device registration, Notified Bodies and Certificates, and Market Surveillance. Their use became mandatory six months later, on 28 May 2026. Devices already on the market before that date have until 28 November 2026 to be registered in the UDI/Device module [1].
Separately, Commission Implementing Regulation (EU) 2025/1234 added a paragraph 3 to Article 7 of the eIFU implementing regulation (EU) 2021/2226: manufacturers providing eIFU shall submit the internet address of the electronic instructions to the UDI database, in line with Annex VI, Part B, point 22 of the MDR, from the date device registration applies under Article 123(3)(d) and (e) of the MDR [2]. That date has now arrived.
The two deadlines therefore meet: a legacy device registered by 28 November 2026 that is supplied with eIFU needs its eIFU address in the record.
Article 7(2) of Regulation 2021/2226 sets the properties of the address and of the site behind it [3]:
A URL on the corporate website that depends on a content management system, a marketing agency or a domain renewal is a risk against every one of these. A deep link that changes with the next redesign is a non-conformity waiting for the next audit.
Which devices may be supplied with eIFU at all, in the EU and in the other major markets, is covered in our market-by-market review of the legal status of eIFU [5].
Many manufacturers are discovering that they have an eIFU, but not an eIFU address they are willing to commit to for 15 years. That is the gap eLeaflet™ by myHealthbox closes: every product published on eifu.me gets a stable, product-level URL on the global eIFU search engine and, if you want it, on your own yourcompany.eifu.me site, with full version history, no login, and infrastructure validated against EU GMP Annex 11 and FDA 21 CFR Part 11. We can load a product range in days. Request a demo if 28 November is close.
This article is a regulatory overview for information purposes, current as of 16 November 2026. It is not legal advice. Check the official texts, which are linked above, before taking a product decision.
Wir verwenden technische Cookies, um diese Website zu betreiben. Mit Ihrer Einwilligung verwenden wir außerdem Google Analytics, um Besuche zu messen. Sie können Ihre Wahl jederzeit über „Cookie-Einstellungen“ unten auf jeder Seite ändern. Datenschutz- und Cookie-Richtlinie